Flexbumin Injection, Solution
Product Images NDC 0944-0495

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Flexbumin (NDC 0944-0495). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Flexbumin 01

Flexbumin 01
Albumin (Human) is a solution for infusion used intravenously in a single-dose container. It contains 12.5g albumin and is stabilized with sodium caprylate and N-acetyltryptophan. The solution does not contain any preservative and has a sodium content of 145 £ 15 mEQL. It must not be used if turbid and administration should not begin more than 4 hours after the container has been entered. The solution should be discarded if there are any leaks or if a partially used container is found. It is essential to check for minute leaks by squeezing the bag firmly. This registered trademark solution is manufactured by Baxalta US Inc. and stored at room temperature not to exceed 25°C (77°F). The TAKEDA® and TAKEDA Logo® are registered trademarks of Takeda Pharmaceutical Company Limited.*
FDA Label Image

Flexbumin 02

Flexbumin 02
This appears to be a label for a medication containing Albumin (Human). The medication is stored at room temperature and should not be frozen. The label contains information on the manufacturer and the product code. It is for intravenous use and comes in single-dose containers. The text also includes dosage and safety information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.